Skip to main content
TipRanks
Go Ultimate75% OFF

CSPC Pharmaceutical Group (1093) Income Statement

35 Followers

CSPC Pharmaceutical Group Income Statement

Last quarter (Q2 2026), CSPC Pharmaceutical Group's total revenue was HK$18.34B, an increase of 11.72% from the same quarter last year. In Q2, CSPC Pharmaceutical Group's net income was HK$6.01B. See CSPC Pharmaceutical Group’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
HK$ 25.33BHK$ 29.54BHK$ 31.47BHK$ 31.59BHK$ 27.41B
HK$ 16.62BHK$ 20.67BHK$ 22.19BHK$ 22.73BHK$ 20.79B
HK$ 12.75BHK$ 15.22BHK$ 15.19BHK$ 15.80BHK$ 14.64B
Depreciation and AmortizationHK$ 1.37BHK$ 1.34BHK$ 1.12BHK$ 1.05BHK$ 865.47M
HK$ 5.24BHK$ 7.16BHK$ 8.59BHK$ 8.83BHK$ 7.58B
HK$ 3.87BHK$ 5.45BHK$ 7.01BHK$ 6.93BHK$ 6.14B
HK$ 815.45MHK$ 229.71MHK$ 388.72MHK$ 811.55MHK$ 591.96M
HK$ 4.68BHK$ 5.68BHK$ 7.39BHK$ 7.74BHK$ 6.73B
HK$ 3.78BHK$ 4.41BHK$ 5.88BHK$ 6.22BHK$ 5.51B
Per Share Metrics
Basic EPSHK$ 0.33HK$ 0.38HK$ 0.50HK$ 0.52HK$ 0.46
Diluted EPSHK$ 0.33HK$ 0.38HK$ 0.49HK$ 0.52HK$ 0.46
Weighted Average Shares Outstanding11.42B11.74B11.87B11.92B11.95B
Weighted Average Shares Outstanding (Diluted)11.42B11.74B11.87B11.92B11.95B

Currency in HKD

CSPC Pharmaceutical Group Earnings and Revenue History

012B24B36B12 %15 %18 %21 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin